THE THALIDOMIDE TRUST
Financial health, per its FY2025 accounts
The accounts state that the charity holds unrestricted reserves of £145m, supported by an investment portfolio of £155m and ongoing funding from Diageo and UK Health Departments. The trustees report that the charity has adequate resources to continue in operations for a minimum of 12 months from the date of signing, with no material uncertainties identified regarding its ability to continue as a going concern.
What the accounts disclose
“The Trustees have to set a policy which will ensure reserves are not depleted whilst beneficiaries are in need of funding, whilst at the same time aiming to ensure that all assets are utilised by the time of the death of the last beneficiary.” — page 15
Structured financials (annual return, FY ending 30/09/2025)
Trustees
- THALIDOMIDE TRUST COMPANY
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £28.6m | £38.1m |
| 30/09/2024 | £30.2m | £39.5m |
| 30/09/2023 | £29.8m | £68.1m |
| 30/09/2022 | £31.0m | £34.1m |
| 30/09/2021 | £27.2m | £32.9m |
Common questions
Is THE THALIDOMIDE TRUST financially healthy?
The accounts state that the charity holds unrestricted reserves of £145m, supported by an investment portfolio of £155m and ongoing funding from Diageo and UK Health Departments. The trustees report that the charity has adequate resources to continue in operations for a minimum of 12 months from the date of signing, with no material uncertainties identified regarding its ability to continue as a going concern. Its FY2025 accounts were audited by Saffery LLP.